Category: Red Blood Cell

Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 

Posted on | Posted on John Murphy | Leave a Comment on Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 

Stefania Campana; Claudia De Pasquale; Giacomo Sidoti Migliore;, et. al. J Immunol (2022) 209 (4): 655–659. https://doi.org/10.4049/jimmunol.2200021 Abstract Proinflammatory monocytes play a preponderant role in the development of a cytokine storm causing fatal consequences in coronavirus disease 2019 (COVID-19) patients, highlighting the importance of analyzing in more detail monocyte distribution in these patients. In this study, […]

Hematological alterations associated with long COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Hematological alterations associated with long COVID-19

Guilherme C. Lechuga1,2,3Carlos M. Morel1Salvatore Giovanni De-Simone1,2,4*, Front. Physiol., 23 July 2023Sec. Red Blood Cell Physiology, Volume 14 – 2023 | https://doi.org/10.3389/fphys.2023.1203472 Long COVID-19 is a condition characterized by persistent symptoms lasting beyond the acute phase of COVID-19. Long COVID-19 produces diverse symptomatology and can impact organs and systems, including the hematological system. Several studies have […]

Anemia in patients with Covid-19: pathogenesis and clinical significance

Posted on | Posted on John Murphy | Leave a Comment on Anemia in patients with Covid-19: pathogenesis and clinical significance

Gaetano Bergamaschi 1, Federica Borrelli de Andreis 2 3, et.al. Observational Study Clin Exp Med2021 May;21(2):239-246. doi: 10.1007/s10238-020-00679-4. Epub 2021 Jan 8. Abstract COVID-19 patients typically present with lower airway disease, although involvement of other organ systems is usually the rule. Hematological manifestations such as thrombocytopenia and reduced lymphocyte and eosinophil numbers are highly prevalent in COVID-19 and have prognostic significance. Few data, […]

Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?

Posted on | Posted on John Murphy | Leave a Comment on Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?

Authors: Shotaro Tabata 1, Hiroki Hosoi 2, Shogo Murata 1, Satomi Takeda 1, Toshiki Mushino 1, Takashi Sonoki 1PMID: 34920343 PMCID: PMC8668346I: 10.1016/j.jaut.2021.102782 J Autoimmun. 2022 Jan; 126: 102782.Published online 2021 Dec 14. doi: 10.1016/j.jaut.2021.102782 Abstract The development of various autoimmune diseases has been reported after COVID-19 infections or vaccinations. However, no method for assessing the relationships between vaccines and the development of autoimmune diseases has been established. Aplastic anemia (AA) is […]